跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TIBELLA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TIBELLA
Authorized
STANDARD
TIBELLA
biosyent pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
03280d3990f5d67c
Company
biosyent pharma inc
Type
Standard
Approval Details
Approval Id
03280d3990f5d67c
Drug Approval Canada Name
TIBELLA
Product Name
TIBELLA
Status
Marketed
Status Date
2020-07-29
Original Market Date
2020-07-29
Din
02488361
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Schedule G (CDSA IV)
Ahfs
68:16.00
Atc Original
G03CX01 TIBOLONE
Atc Name
g 03 cx 01
Aig Number
0161430001
Company Name
biosyent pharma inc
Company Address
SUITE 402, 2476 Argentia Road, Mississauga, Ontario, Canada, L5N 6M1
Active Ingredients
TIBOLONE
2.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
03280d3990f5d67c
Type
Standard
Back to Health Canada Approvals